Chantal reports third quarter sales of $2 mil. on cash basis reporting.
This article was originally published in The Rose Sheet
Executive Summary
CHANTAL PHARMACEUTICAL THIRD QUARTER SALES OF $2 MIL. for the period ended March 31 are reported by Chantal in a 10-Q filed May 21. Sales, reported on a cash basis, are 28.1% below sales for the comparable period in 1995. The company recorded a $3.4 mil. net loss for the quarter versus net income of $408,752 in the prior-year period.